Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Bd is conducting a voluntary product recall of several bd catalogues of luer-lok syringes and luer-lok syringe with precisionglide needle since the sterility of the product cannot be assured. this may result in increased risk of infection. no adverse event has been reported for this issue at this time. bd is actively working on implementing corrective actions to address this issue.